Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-22 | LLB Swiss Investment AGUnternehmen | -3,85M | 100,79k | Verkauf | 0,03 | 41,15M | -8,55% |
| 2026-04-15 | Condire Investors, LLCUnternehmen | 191,00M | 5,56M | Kauf | 0,03 | 289,38M | 194,15% |
| 2026-04-15 | Canaccord Genuity Asset Management LimitedUnternehmen | 65,63M | 0,00 | Kauf | - | 112,63M | 139,63% |
| 2026-04-21 | Mr. Sam PazukiMD, CEO & Executive Director | -4,32M | 0,00 | Other Derivative Disposition | - | 4,31M | -50,09% |
| 2026-04-15 | Mr. Sam PazukiMD, CEO & Executive Director | 851,06k | 29,12k | Kauf | 0,03 | 8,57M | 11,03% |
| 2026-04-21 | Mr. Sam PazukiMD, CEO & Executive Director | -1,47M | 0,00 | Other Derivative Disposition | - | 25,30M | -5,51% |
| 2026-04-16 | Cupel Advisory CorpUnternehmen | 1.000,00k | 29,17k | Kauf | 0,03 | 2,18M | 84,75% |
| 2026-04-16 | Mr. James Carr WithallIndependent Non-Executive Director | 350,00k | 10,21k | Kauf | 0,03 | 1,35M | 35,00% |
| 2026-04-14 | Condire Investors, LLCUnternehmen | 191,00M | 5,55M | Kauf | 0,03 | 289,38M | 194,15% |
| 2026-04-15 | Franklin Resources, Inc.Unternehmen | 75,00M | 2,15M | Kauf | 0,03 | 118,53M | 172,31% |
| 2026-04-14 | Nokomis Capital, L.L.C.Unternehmen | 135,00M | 3,85M | Kauf | 0,03 | 135,00M | - |
| 2026-03-05 | Condire Investors, LLCUnternehmen | 98,38M | 3,90M | Kauf | 0,04 | 98,38M | - |
| 2024-12-10 | B2Gold Corp.Unternehmen | 27,00M | 860,14k | Kauf | 0,03 | 31,01M | 673,27% |
| 2025-12-10 | Mr. Justin OsborneIndependent Non-Executive Chairman | 1.000,00k | 24,57k | Kauf | 0,02 | 2,94M | 51,52% |
| 2025-12-10 | Cupel Advisory CorpUnternehmen | 300,00k | 9,02k | Kauf | 0,03 | 1,18M | 34,09% |
| 2025-12-10 | Mr. Justin OsborneIndependent Non-Executive Chairman | 1.000,00k | 24,57k | Kauf | 0,02 | 2,79M | 55,84% |
| 2025-12-05 | Cupel Advisory CorpUnternehmen | 200,00k | 6,49k | Kauf | 0,03 | 880,00k | 29,41% |
| 2025-12-04 | Mr. Sam PazukiMD, CEO & Executive Director | 350,00k | 8,28k | Kauf | 0,02 | 7,72M | 4,75% |
| 2025-12-03 | Mr. James Carr WithallIndependent Non-Executive Director | 500,00k | 14,34k | Kauf | 0,03 | 1.000,00k | 100,00% |
| 2025-12-03 | Mr. Sam PazukiMD, CEO & Executive Director | 957,58k | 25,63k | Kauf | 0,02 - 0,03 | 7,37M | 14,94% |
| 2025-10-23 | Mr. Sam PazukiMD, CEO & Executive Director | 1,08M | 76,91 | Derivative Exercise and Retained Stock | 0,00 | 6,41M | 20,34% |
| 2025-07-15 | LLB Swiss Investment AGUnternehmen | 10,31M | 229,00k | Kauf | 0,02 | 45,00M | 29,73% |
| 2025-05-23 | LLB Swiss Investment AGUnternehmen | -822,06k | 18,72k | Verkauf | 0,02 | 45,00M | -1,79% |
| 2025-05-26 | LLB Swiss Investment AGUnternehmen | -898,94k | 20,04k | Other Disposition | 0,02 | 45,00M | -1,96% |
| 2025-07-18 | Ms. Carol MarinkovichExecutive Director & Company Secretary | 540,88k | 0,00 | Derivative Exercise and Retained Stock | - | 865,39k | 166,68% |
| 2025-07-04 | Ms. Carol MarinkovichExecutive Director & Company Secretary | 540,88k | 10,98k | Derivative Exercise and Retained Stock | 0,02 | 324,50k | -249,97% |
| 2025-07-18 | Mr. Sam PazukiMD, CEO & Executive Director | 1,08M | 41,71k | Derivative Exercise and Retained Stock | 0,02 - 0,04 | 6,41M | 20,34% |
| 2025-07-04 | Cupel Advisory CorpUnternehmen | 1,25M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 1,25M | - |
| 2025-07-04 | Mr. Ryan FinkelsteinCFO | 559,94k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,04 | 559,94k | - |
| 2025-07-04 | Mr. Ryan FinkelsteinCFO | 1,34M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 1,34M | - |
| 2025-07-07 | Mr. Michael Bethel SkeadPresident | 6,00M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,04 | 8,56M | 234,67% |
| 2025-07-04 | Mr. Sam PazukiMD, CEO & Executive Director | 3,00M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,04 | 26,78M | 12,62% |
| 2025-07-04 | Mr. Sam PazukiMD, CEO & Executive Director | 5,00M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 12,10M | 70,38% |
| 2025-07-04 | Ms. Carol MarinkovichExecutive Director & Company Secretary | 1,88M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-07-04 | Ms. Carol MarinkovichExecutive Director & Company Secretary | -1,03M | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-07-04 | Mr. Sam PazukiMD, CEO & Executive Director | -4,37M | 0,00 | Other Derivative Disposition | - | - | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
